The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells (Q28242279)

4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide

inferred from title

1 reference

https://scigraph.springernature.com/pub.10.1007/s00439-006-0186-1

ChEBI release 2020-05-28

1 reference

Markus Riessland

1

0 references

author name string

Lars Brichta

series ordinal

2

0 references

Eric Hahnen

series ordinal

3

0 references

Brunhilde Wirth

series ordinal

4

0 references

language of work or name

English

0 references

publication date

August 2006

0 references

published in

Human Genetics

0 references

volume

120

0 references

issue

1

0 references

page(s)

101-10

0 references

exact match

0 references

cites work

An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).

1 reference

12 December 2020

Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly

1 reference

12 December 2020

A novel nuclear structure containing the survival of motor neurons protein

1 reference

12 December 2020

1 reference

12 December 2020

International SMA consortium meeting. (26-28 June 1992, Bonn, Germany)

1 reference

12 December 2020

The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins

1 reference

12 December 2020

Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1

1 reference

12 December 2020

A mouse model for spinal muscular atrophy

1 reference

12 December 2020

SMN oligomerization defect correlates with spinal muscular atrophy severity

1 reference

12 December 2020

SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN

1 reference

12 December 2020

In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate

1 reference

12 December 2020

Amide Analogues of Trichostatin A as Inhibitors of Histone Deacetylase and Inducers of Terminal Cell Differentiation

1 reference

12 December 2020

In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy

1 reference

12 December 2020

A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing

1 reference

12 December 2020

An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA

1 reference

12 December 2020

A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy

1 reference

12 December 2020

Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy

1 reference

12 December 2020

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy

1 reference

12 December 2020

Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.

1 reference

12 December 2020

Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

1 reference

12 December 2020

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

1 reference

12 December 2020

The role of histone acetylation in SMN gene expression.

1 reference

12 December 2020

Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism

1 reference

12 December 2020

A clinical and genetic study of spinal muscular atrophy of adult onset: the autosomal recessive form as a discrete disease entity

1 reference

12 December 2020

Correlation between severity and SMN protein level in spinal muscular atrophy

1 reference

12 December 2020

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients

1 reference

12 December 2020

When is a deletion not a deletion? When it is converted

1 reference

12 December 2020

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

12 December 2020

What's up and down with histone deacetylation and transcription?

1 reference

12 December 2020

Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

1 reference

12 December 2020

Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275.

1 reference

12 December 2020

Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons

1 reference

12 December 2020

Treatment of spinal muscular atrophy by sodium butyrate

1 reference

12 December 2020

The survival motor neuron protein in spinal muscular atrophy

1 reference

12 December 2020

Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients

1 reference

12 December 2020

SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1

1 reference

12 December 2020

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

1 reference

12 December 2020

Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization.

1 reference

12 December 2020

An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN

1 reference

12 December 2020

SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis

1 reference

12 December 2020

Identification and characterization of a spinal muscular atrophy-determining gene

1 reference

12 December 2020

Genetic basis of adult-onset spinal muscular atrophy

1 reference

12 December 2020

Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells

1 reference

12 December 2020

Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?

1 reference

12 December 2020

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

1 reference

12 December 2020

Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)

1 reference

12 December 2020

hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1

1 reference

12 December 2020

Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes.

1 reference

12 December 2020